Tradestie Institutional Equity Comparison Engine
BMNU vs CRCA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CRCA Overall Edge
CRCA Captures Institutional Edge (2โ0 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares Ultra CRCL (CRCA) driven by superior Momentum & Technical, Options & Structure. Fundamentally, BMNU trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CRCA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BMNU sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against CRCA sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BMNU N/M vs CRCA N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
CRCA
1Y -37.0% vs +61.0% ยท 52W Pos 26% vs 7%
Options & Structure Winner
CRCA
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
BMNU
Cboe BZX
T-REX 2X Long BMNR Daily Target ETF
Institutional Equity
$7.04
-14.56% 1D
Market Cap
N/A
1M Return
-47.89%
1Y Return
-37.03%
Forward P/E
N/M
Unified AI Score
49.7 / 100
HOLD
Tech 38.0
Fund 57.0
Flow 50.0
Mom 60.0
CRCA
NYSE Arca
ProShares Ultra CRCL
Institutional Equity
$7.84
-14.5% 1D
Market Cap
N/A
1M Return
-53.61%
1Y Return
+60.99%
Forward P/E
N/M
Unified AI Score
51.0 / 100
HOLD
Tech 53.0
Fund 54.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BMNU -37.03%
CRCA +60.99%
Spread: +98.02 pp (CRCA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BMNU TTM Op. Margin: N/A
CRCA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BMNU vs CRCA. Trailing 12-month operating profitability (BMNU N/A vs CRCA N/A) and valuation multiples (BMNU N/M vs CRCA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BMNU | CRCA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 26% ($1โ$25) | 7% ($1โ$93) | Stronger Trend | BMNU |
| Beta / 30D Volatility Risk Regime | 1.38ฮฒ ยท 164% Vol | 4.88ฮฒ ยท 137% Vol | Lower Realized Risk | CRCA |
| Unified Institutional Score Composite Signal | 49.7 / 100 (HOLD) | 51.0 / 100 (HOLD) | Higher Composite | CRCA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BMNU vs CRCA Buy Guide
BMNU
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
CRCA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BMNU nor CRCA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.